Vanguard Group’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.5M | Sell |
|
|||||
|
2025
Q2 | $9.12M | Sell |
|
|||||
|
2025
Q1 | $7.24M | Buy |
|
|||||
|
2024
Q4 | $13M | Sell |
|
|||||
|
2024
Q3 | $24.2M | Buy |
|
|||||
|
2024
Q2 | $20.5M | Buy |
|
|||||
|
2024
Q1 | $25.8M | Buy |
|
|||||
|
2023
Q4 | $977K | Buy |
|
|||||
|
2023
Q3 | $796K | Sell |
|
|||||
|
2023
Q2 | $839K | Sell |
|
|||||
|
2023
Q1 | $711K | Hold |
|
|||||
|
2022
Q4 | $517K | Sell |
|
|||||
|
2022
Q3 | $657K | Sell |
|
|||||
|
2022
Q2 | $1.16M | Sell |
|
|||||
|
2022
Q1 | $2.41M | Sell |
|
|||||
|
2021
Q4 | $7.71M | Sell |
|
|||||
|
2021
Q3 | $11.6M | Buy |
|
|||||
|
2021
Q2 | $14.7M | Buy |
|
|||||
|
2021
Q1 | $18.7M | Buy |
|
|||||
|
2020
Q4 | $16.3M | Buy |
|
|||||
|
2020
Q3 | $13.1M | Buy |
|
|||||
|
2020
Q2 | $16.5M | Buy |
|
|||||
|
2020
Q1 | $6M | Buy |
|
|||||
|
2019
Q4 | $6.43M | Buy |
|
|||||
|
2019
Q3 | $699K | Sell |
|
|||||
|
2019
Q2 | $808K | Hold |
|
|||||
|
2019
Q1 | $924K | Hold |
|
|||||
|
2018
Q4 | $740K | Hold |
|
|||||
|
2018
Q3 | $1M | Buy |
|
|||||
|
2018
Q2 | $882K | Buy |
|
|||||
|
2018
Q1 | $4.45M | Buy |
|
|||||
|
2017
Q4 | $3.5M | Buy |
|
|||||
|
2017
Q3 | $4.19M | Buy |
|
|||||
|
2017
Q2 | $3.97M | Buy |
|
|||||
|
2017
Q1 | $4.42M | Buy |
|
|||||
|
2016
Q4 | $4.19M | Buy |
|
|||||
|
2016
Q3 | $2.76M | Buy |
|
|||||
|
2016
Q2 | $731K | Buy |
|
|||||
|
2016
Q1 | $955K | Buy |
|
|||||
|
2015
Q4 | $1.18M | Buy |
|
|||||
|
2015
Q3 | $445K | Buy |
|